Contemporary Pediatrics
banner
contemppeds.bsky.social
Contemporary Pediatrics
@contemppeds.bsky.social
Practical Information for Today's Pediatrician
The FDA has approved BioCryst Pharmaceuticals, Inc.'s berotralstat (#ORLADEYO) prophylactic oral pellets for pediatric patients aged 2 to <12 years with HAE.

Berotralstat is now the first targeted oral prophylactic for this indication.

FULL DETAILS: www.contemporarypediatrics.com/view/fda-app...
December 12, 2025 at 2:39 PM
Breaking #FDA news:

The federal agency has approved GSK's gepotidacin (Blujepa) as an oral option to treat uncomplicated urogenital #gonorrhea in patients aged 12 years and older weighing at least 45 kg.

Full details: www.contemporarypediatrics.com/view/fda-app...
December 11, 2025 at 7:38 PM
If you missed it:

The FDA is launching a safety review of #RSV preventive monoclonal antibodies #nirsevimab and #clesrovimab. Reuters reported that FDA officials made inquiries into the RSV preventive therapies in the summer. #medsky

Full details: www.contemporarypediatrics.com/view/reports...
December 11, 2025 at 5:42 PM
In light of today's #ACIP meeting, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, explains that the foundation is recommending that #infants continue to receive the birth dose of the hepatitis B #vaccine.

Watch:
www.contemporarypediatrics.com/view/hepatit...
December 5, 2025 at 10:17 PM
NEW TODAY:

The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.

View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
December 5, 2025 at 4:21 PM
Josh Feder, MD, explains applied behavioral analysis, part of a larger discussion of the recent recommendations from the American Academy of Child and Adolescent Psychiatry (@AACAP) to improve and expand access to #autism care.
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
December 3, 2025 at 8:47 PM
The open-label trial will assess safety, tolerability, pharmacodynamics, and preliminary efficacy in adults before expanding into a pediatric cohort.

#Pediatrics #Immunology #RareDisease #GeneTherapy

READ MORE: www.contemporarypediatrics.com/view/first-p...
December 1, 2025 at 5:09 PM
In our latest #puzzler quiz, try to diagnose this 8-year-old girl with a corneal lesion.

View some case details below, then click the link for more information and to make your diagnosis.

Can you diagnose this patient?

View more: www.contemporarypediatrics.com/view/can-you...
November 24, 2025 at 6:28 PM
New from the FDA:

The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky

More details to come on contemporarypediatrics.com.
November 17, 2025 at 2:31 PM
Arcutis Biotherapeutics has announced the commercial launch of #roflumilast 0.05% for the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.

Arcutis stated the topical formulation will be available in pharmacies this week.

www.contemporarypediatrics.com/view/lawrenc...
October 30, 2025 at 1:26 PM
In this Q&A discussion, study investigator of zoliflodacin, Sarah McLeod, PhD, highlights phase 3 data on the drug's efficacy against multidrug-resistant Neisseria #gonorrhoeae. #IDWeek #medsky #pedsky

Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
October 27, 2025 at 8:46 PM
Also new today out of #FallClinical2025 in Vegas:

Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.

MORE: www.contemporarypediatrics.com/view/fall-cl...
October 24, 2025 at 5:02 PM
Announced at the 2025 @fallclinical #Dermatology Conference in Las Vegas:

Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky

Full coverage: www.contemporarypediatrics.com/view/fall-cl...
October 24, 2025 at 4:53 PM
The #FDA has expanded pediatric indications for adalimumab-aaty (Yuflyma; Celltrion USA) and unbranded adalimumab-aaty to include the treatment of hidradenitis suppurativa in adolescent patients aged 12 years and older, and uveitis in pediatric patients aged 2 years and older.
October 17, 2025 at 1:49 PM
Thank you, peace madueme, MD, chief of #Cardiology at @Nemours Children's Hospital in Orlando, Florida, for speaking with us about #ECGs and how they can supplement routine sports physicals for #youth athletes. #medsky

Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
October 14, 2025 at 3:57 PM
If you missed it:

Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.

READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
October 13, 2025 at 6:47 PM
Backup camera mandate linked to fewer severe pediatric backover injuries: Backover trauma occurs when a pedestrian is struck by a motor vehicle in reverse. Researchers reported both fatal and severe injuries in children under age 5 have decreased. #medsky #pedsky

More:
hubs.li/Q03LwvXw0
September 30, 2025 at 3:05 PM
The study, "The Association of Maternal Adverse Childhood Experiences with Preterm Birth of Their Infants," found that #mothers with 2 or more ACEs were nearly twice as likely to deliver #preterm as those with fewer or no ACEs.

Read more: hubs.li/Q03Lwwht0
September 30, 2025 at 3:05 PM
Michael Levas, MD, of Project Ujima and Children's Wisconsin presented data at the 2025 AAP National Conference that demonstrated nearly 1 in 4 children with #firearm injuries had prior #ED visits for crashes or violence. #AAP

More on this association: hubs.li/Q03LwqWB0
September 30, 2025 at 3:04 PM
New research published at the 2025 AAP National Conference has revealed an emerging #suicide method that involves the ingestion of sodium nitrite. The method is increasingly being used by adolescents and young adults. #AAP

More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
September 30, 2025 at 2:50 PM
In another video interview from the 2025 AAP National Conference & Exhibition, Diane Straub, MD, of Children's Hospital Colorado, discussed the current climate related to adolescent sexual health.

Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
September 29, 2025 at 4:42 PM
From the AAP National Conference & Exhibition:

Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.

Full interview: www.contemporarypediatrics.com/view/melanie...
September 29, 2025 at 4:20 PM
According to a presentation at the 2025 AAP National Conference & Exhibition in Denver, #opioid exposures among US-children are showing concerning trends, with steady increases in pre-teen cases over the past 5 years. #medsky

Full study details: www.contemporarypediatrics.com/view/emergen...
September 26, 2025 at 7:54 PM
Today marks the first day of the 2025 @AAPexperience from Denver, Colorado! #medsky #pedsky

Follow us on our website, contemporarypediatrics.com, for continued coverage, including expert interviews.

More: www.contemporarypediatrics.com/view/aap-202...
September 26, 2025 at 1:53 PM
Today, the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report stated the federal agency recorded the most pediatric, influenza-associated deaths since the 2009-10 season, with 280 deaths reported.

Full data analysis: www.contemporarypediatrics.com/view/cdc-rep...
September 25, 2025 at 7:13 PM